How Could Marginalized Groups Be Impacted by the Digital Divide?
Artificial intelligence (AI) has potential to help alleviate clinician burnout and address health disparities, but some technologies might not be accessible to all groups. Kevin Johnson, MD, MS, University Professor of Biomedical Informatics, Computer Science, Pediatrics, and Science Communication at the University of Pennsylvania, Vice President of Applied Clinical Informatics in the Penn Medicine, University of Pennsylvania Health System, shares insights during TDC Group’s 2024 Executive Advisory Board Meeting.
Search
Professional Education
Loss Lessons: Recognition of Wernicke Encephalopathy
Wernicke encephalopathy (WE) is a syndrome commonly seen in patients with alcohol use disorder who do not take adequate thiamine. WE should be suspected in any patient with conditions that may lead to malnutrition in combination with any of the following symptoms: altered mental status ophthalmoplegia, ataxia, delirium, and hypotension. Considered a medical emergency, it must be reversed to prevent permanent deficits. This case illustrates a cascade of errors which led to permanent disability. Some practical interventions to quickly recognize and reverse the condition are offered following the case presentation, which will be helpful for gastroenterology/gastroenterologists, ophthalmology/ophthalmologists, and neurology/neurologists.
As Corporate Entities Enter Healthcare, Practices Can Respond via Patient-Centered Care
Corporate entities have always been involved in healthcare, but now mega corporations—from outside the medical space—are entering the field. The involvement of these large non-legacy corporate entities in healthcare is growing and is challenging—and while this trend brings some benefits, it will also impact how all clinicians provide healthcare.
Dec 15, 2022
The Clinician Voice Post-Roe: Speaking Up for Standards of Care
The spillover effects of the Supreme Court’s Dobbs decision, which overturned Roe v. Wade, mean that many clinicians face uncertainty regarding which treatment practices are still legal in their state. Accordingly, they may be unsure how to communicate with patients, or uncertain regarding their role in their institution’s planning conversations.
February 21, 2024, Journal of the American College of Cardiology
Professional Liability: The Problem That Will Not Go Away
The frequency of malpractice claims in the United States has trended downward in the last 10 to 15 years, however, there is an upward trend in the “severity” of claims, driven in large part by “nuclear” jury verdicts. Cardiologists and other clinicians should always be aware that a lack of communication is a common causal factor in malpractice suits. Richard E. Anderson, MD, FACP, Chairman and CEO, The Doctors Company and TDC Group, investigates claim amounts and severity alongside three prominent physicians.
December 15, 2023, Inside Medical Liability
MPL Cases: What Are the Primary Drivers of High-Indemnity Medical Malpractice Claims?
Jacqueline Ross, RN, PhD, Coding Director, and Kathrine Soulsby, RN, BSN, Senior Patient Safety Analyst, The Doctors Company, part of TDC Group, investigate high-dollar medical malpractice litigation and explain how reducing diagnostic errors is paramount to enhancing patient safety and mitigating loss costs.
The Doctors Company Awarded Great Place to Work Certification for Third Time
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced today it has been Certified as a Great Place to Work for the third time. The recognition is based entirely on what current employees say about working at The Doctors Company, with 89 percent of employees saying it’s a great place to work.
December 01, 2024, South Florida Hospital News and Healthcare Report
The Rising Threat of Nuclear Verdicts in Medical Malpractice: A Call for Tort Reform
Dr. Patricia Ares-Romero discusses the increasing trend of "nuclear verdicts"—jury awards exceeding $10 million—in medical malpractice cases. She highlights insights from Bob White, President of The Doctors Company and TDC Group, noting that from 2013 to 2023, these verdicts surged by 67%, with the average award among the top 50 malpractice verdicts rising from $32 million in 2022 to $48 million in 2023.
Nonadherent and Noncompliant Patients: Overcoming Barriers
Nonadherent or noncompliant patient conduct (whether intentional or inadvertent) can adversely affect clinical outcomes, undermine the practitioner-patient relationship, and disrupt the operation of practice.
NJ PURE Announces Exclusive Agreement with The Doctors Company Risk Retention Group for Industry-Leading Malpractice Coverage
NJ Physicians United Reciprocal Exchange (NJ PURE) announced today it is exiting the medical malpractice insurance marketplace and has entered into a relationship designed to offer its insureds access to a leading A rated medical liability carrier with The Doctors Company Risk Retention Group (RRG).
